W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY
|
Back to Search Results |
|
Catalog Number VBHR100502W |
Device Problems
Material Fragmentation (1261); Activation Failure (3270)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 02/29/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
The following was reported to gore: on (b)(6) 2024, a patient was to be implanted with 10mm x 5cm gore® viabahn® endoprosthesis with heparin bioactive surface (viabahn device) to treat as carotid chimney during taa hybrid procedure.The viabahn device was advanced via 180cm terumo wire to target lesion.The deployment line was broken when it was pulled about around 10cm.The viabahn device couldn't be deployed.Then the physician removed the viabahn device out of patient.Another viabahn device with same size was utilized to complete the procedure.The patient tolerated the procedure.
|
|
Manufacturer Narrative
|
H6: c19 - a review of manufacturing records verified that the lot involved in this complaint met all pre-release specifications.Evaluation of returned items was able to confirm the report of deployment difficulty (i.E., broken deployment line); however, the cause of deployment difficulty could not be established as the conditions present during the procedure that may have contributed to the reported complication could not be replicated during evaluation.Procedural and benchtop deployment of the device can be impacted by different factors including but not limited to zipper integrity, delivery system support or stiffness, or presence of dried fluid on the device or within the catheter dual lumen.Additionally, the device has been manipulated in the field and is no longer representative of its condition prior to use.Deployment was resumed with traction at the endoprosthesis, and there were no remarkable observations noted with respect to deployment performance.
|
|
Search Alerts/Recalls
|
|
|